| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | CLOVIS ONCOLOGY INC | 298,982 | 13,281,000 | 8.01% | ||
| 2 | QIAGEN NV | 438,572 | 12,289,000 | 7.42% | ||
| 3 | TESARO INC | 89,695 | 12,062,000 | 7.28% | ||
| 4 | IRONWOOD PHARMACEUTICALS INC COM CL A | 772,369 | 11,810,000 | 7.13% | ||
| 5 | BARD C R INC | 52,377 | 11,767,000 | 7.10% | ||
| 6 | ALEXION PHARMACEUTIC | 90,134 | 11,028,000 | 6.65% | ||
| 7 | HOLOGIC INC | 273,478 | 10,972,000 | 6.62% | ||
| 8 | INCYTE | 109,371 | 10,967,000 | 6.62% | ||
| 9 | LABORATORY CORP AMER HLDGS | 85,000 | 10,912,000 | 6.58% | ||
| 10 | BOSTON SCIENTIFIC CORP | 498,303 | 10,778,000 | 6.50% | ||
| 11 | SHIRE PLC | 62,500 | 10,649,000 | 6.43% | ||
| 12 | DERMIRA INC | 350,000 | 10,616,000 | 6.41% | ||
| 13 | BRISTOL MYERS SQUIBB CO | 170,000 | 9,935,000 | 6.00% | ||
| 14 | EDWARDS LIFESCIENCES CORP | 103,029 | 9,654,000 | 5.83% | ||
| 15 | RESMED INC | 145,000 | 8,997,000 | 5.43% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001144204-17-008006, filed 2017.02.13).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
